ID

21057

Descripción

Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer.; ODM derived from: https://clinicaltrials.gov/show/NCT00314977

Link

https://clinicaltrials.gov/show/NCT00314977

Palabras clave

Versiones (1)
  1. 6/4/17 6/4/17 -
Subido en

6 de abril de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT00314977

Inglés

Eligibility Breast Cancer NCT00314977

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
women presenting with large resectable or locally advanced breast cancer (t2 ≥3 cm, t3, or t4, and/or ln positive)
Descripción

breast cancer stage

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0027646
measurable disease (breast and/or lymph nodes)
Descripción

measurable disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C1513041
no prior surgery other than biopsy and no prior chemotherapy or radiation therapy
Descripción

no prior therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1514463
age ≥18 years and age ≤70 years
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
karnofsky performance score ≥70%
Descripción

karnofsky performance score

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0206065
estrogen and/or progesterone receptor analysis performed on the primary tumour in the biopsy material
Descripción

hormone receptor status

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0019929
UMLS CUI [1,3]
C0449438
in case the tumor is er/pgr ³ 50% positive, (neo)adjuvant hormonal therapy in stead of chemotherapy should be considered (e.g. in team ii study)
Descripción

hormone receptor status

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0019929
UMLS CUI [1,3]
C0449438
her2/neu receptor analysis performed on the primary tumour in the biopsy material
Descripción

her2/neu status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1512413
adequate bone marrow function (within 14 days prior to registration): wbc ≥3.0 x 109/l, neutrophils ≥1.5 x 109/l, platelets ≥100 x 109/l
Descripción

bone marrow function

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1254358
UMLS CUI [1,2]
C0005953
UMLS CUI [2]
C002350
UMLS CUI [3]
C0200633
UMLS CUI [4]
C0032181
adequate liver function (within 4 weeks prior to start treatment): bilirubin ≤1.5 x upper limit of normal (unl) range, alat and/or asat ≤2.5 x unl, alkaline phosphatase ≤5 x unl
Descripción

liver function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C0201913
UMLS CUI [3]
C0201836
UMLS CUI [4]
C0201899
UMLS CUI [5]
C0201850
adequate renal function (within 4 weeks prior to start treatment): the calculated creatinine clearance should be ≥50 ml/min
Descripción

renal function

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0232804
UMLS CUI [1,2]
C0151280
patients must be accessible for treatment and follow-up
Descripción

availability treatment and follow-up

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0470187
UMLS CUI [1,2]
C0087111
UMLS CUI [2,1]
C0470187
UMLS CUI [2,2]
C1522577
written informed consent according to the local ethics committee requirements
Descripción

written informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with advanced pulmonary disease of any cause (oxygen dependent)- peripheral neuropathy > grade 2 whatever the cause
Descripción

peripheral neuropathy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0031117
serious other diseases as recent myocardial infarction, clinical signs of cardiac failure or clinically significant arrythmias
Descripción

cardiac diseases

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0018801
UMLS CUI [3]
C0003811
evidence of distant metastases (m1)
Descripción

distant metastases

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C3258247
patients with a history of breast cancer
Descripción

history of breast cancer

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0678222
patients with a history of another malignancy (except basal cell skin carcinoma and carcinoma-in-situ of the uterine cervix) within 5 years of study entry- pregnant or lactating women, or potentially fertile women not using adequate contraception
Descripción

history of other malignancy, pregnancy, breast feeding, child bearing potential

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0205394
UMLS CUI [2]
C0032961
UMLS CUI [3]
C0006147
UMLS CUI [4]
C1960468
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT00314977

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
breast cancer stage
Item
women presenting with large resectable or locally advanced breast cancer (t2 ≥3 cm, t3, or t4, and/or ln positive)
boolean
C0678222 (UMLS CUI [1,1])
C0027646 (UMLS CUI [1,2])
measurable disease
Item
measurable disease (breast and/or lymph nodes)
boolean
C0678222 (UMLS CUI [1,1])
C1513041 (UMLS CUI [1,2])
no prior therapy
Item
no prior surgery other than biopsy and no prior chemotherapy or radiation therapy
boolean
C1514463 (UMLS CUI [1])
age
Item
age ≥18 years and age ≤70 years
boolean
C0001779 (UMLS CUI [1])
karnofsky performance score
Item
karnofsky performance score ≥70%
boolean
C0206065 (UMLS CUI [1])
hormone receptor status
Item
estrogen and/or progesterone receptor analysis performed on the primary tumour in the biopsy material
boolean
C0678222 (UMLS CUI [1,1])
C0019929 (UMLS CUI [1,2])
C0449438 (UMLS CUI [1,3])
hormone receptor status
Item
in case the tumor is er/pgr ³ 50% positive, (neo)adjuvant hormonal therapy in stead of chemotherapy should be considered (e.g. in team ii study)
boolean
C0678222 (UMLS CUI [1,1])
C0019929 (UMLS CUI [1,2])
C0449438 (UMLS CUI [1,3])
her2/neu status
Item
her2/neu receptor analysis performed on the primary tumour in the biopsy material
boolean
C1512413 (UMLS CUI [1])
bone marrow function
Item
adequate bone marrow function (within 14 days prior to registration): wbc ≥3.0 x 109/l, neutrophils ≥1.5 x 109/l, platelets ≥100 x 109/l
boolean
C1254358 (UMLS CUI [1,1])
C0005953 (UMLS CUI [1,2])
C002350 (UMLS CUI [2])
C0200633 (UMLS CUI [3])
C0032181 (UMLS CUI [4])
liver function
Item
adequate liver function (within 4 weeks prior to start treatment): bilirubin ≤1.5 x upper limit of normal (unl) range, alat and/or asat ≤2.5 x unl, alkaline phosphatase ≤5 x unl
boolean
C0232741 (UMLS CUI [1])
C0201913 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201899 (UMLS CUI [4])
C0201850 (UMLS CUI [5])
renal function
Item
adequate renal function (within 4 weeks prior to start treatment): the calculated creatinine clearance should be ≥50 ml/min
boolean
C0232804 (UMLS CUI [1,1])
C0151280 (UMLS CUI [1,2])
availability treatment and follow-up
Item
patients must be accessible for treatment and follow-up
boolean
C0470187 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0470187 (UMLS CUI [2,1])
C1522577 (UMLS CUI [2,2])
written informed consent
Item
written informed consent according to the local ethics committee requirements
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
peripheral neuropathy
Item
patients with advanced pulmonary disease of any cause (oxygen dependent)- peripheral neuropathy > grade 2 whatever the cause
boolean
C0031117 (UMLS CUI [1])
cardiac diseases
Item
serious other diseases as recent myocardial infarction, clinical signs of cardiac failure or clinically significant arrythmias
boolean
C0027051 (UMLS CUI [1])
C0018801 (UMLS CUI [2])
C0003811 (UMLS CUI [3])
distant metastases
Item
evidence of distant metastases (m1)
boolean
C0678222 (UMLS CUI [1,1])
C3258247 (UMLS CUI [1,2])
history of breast cancer
Item
patients with a history of breast cancer
boolean
C0262926 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
history of other malignancy, pregnancy, breast feeding, child bearing potential
Item
patients with a history of another malignancy (except basal cell skin carcinoma and carcinoma-in-situ of the uterine cervix) within 5 years of study entry- pregnant or lactating women, or potentially fertile women not using adequate contraception
boolean
C0006826 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0032961 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C1960468 (UMLS CUI [4])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial